Apr 26 |
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
|
Apr 25 |
Merck (MRK) Q1 2024 Earnings Call Transcript
|
Apr 25 |
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
|
Apr 25 |
Merck & Co., Inc. (MRK) Q1 2024 Earnings Call Transcript
|
Apr 25 |
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
|
Apr 25 |
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
|
Apr 25 |
20 Fastest Growing Health Tech Companies in the World
|
Apr 25 |
Merck raises 2024 guidance on cancer drug demand
|
Apr 25 |
Meta Falls 15% On Great Earnings, Tesla Rises 12% On Ugly Earnings – Here Is The Real Reason
|
Apr 25 |
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
|